meditip

LCS Overview

LCS, a Meditip Family brand dedicated to non-clinical strategy and testing site networks

LCS is a specialized non-clinical brand integrated with Meditip's regulatory approval and clinical consulting services.

We specialize in brokering non-clinical services and providing regulatory approval consulting required for the development of new substances across pharmaceuticals, foods, cosmetics, and medical devices.

Beyond simple consulting, we provide customized, optimal solutions ranging from test protocol development and non-clinical report preparation to CRO connections, based on a collaborative network of specialized research institutions in each field.

Through extensive practical experience, expert personnel, and a network of partner institutions, we support our clients' successful product development and commercialization.

Leadership

  • CEO Chae-sung Lim

    Based on non-clinical strategy and GLP-based business development experience, he suggests the optimal development direction.

    • Non-clinical Strategy / GLP / Business Development

  • Vice President Jae-min Kim

    Based on efficacy evaluation and medical device non-clinical expertise, he supports research outcomes.

    • Efficacy of pharmaceuticals and health functional foods / medical device performance and safety testing consulting

Business Areas

Non-clinical Consulting Services

LCS provides non-clinical services across the entire new substance development cycle, from the Lead Optimization stage to non-clinical strategy establishment for IND / NDA, domestic and international CRO quotations and test outsourcing, and pharmaceutical and medical device efficacy evaluation.

  • Lead Optimization R&D Services

    We support efficacy, safety, and DMPK strategy establishment and testing for Lead candidate substance optimization.

    • Efficacy Evaluation

    • Non-GLP Toxicity

    • DMPK

    • Rodent / Non-rodent

  • IND / NDA Non-clinical Consulting

    We support IND / NDA non-clinical strategies for new drugs, herbal medicines, biopharmaceuticals, and medical devices.

    • New Drugs

    • Bio

    • Medical Devices

    • Non-clinical Strategy

  • Health Functional Foods Non-clinical Consulting

    We support non-clinical strategies for individually approved health functional foods and temporary food ingredient approval.

    • Individually Approved

    • Food Ingredients

    • Safety

    • Approval Strategy

  • Domestic & International CRO Quotation and Proposal Support

    Based on domestic and international CRO networks, we provide optimal quotations and test period estimates.

    • USA

    • Europe

    • Japan

    • China

  • CTD Preparation Support

    Based on non-clinical data, we support pharmaceutical CTD document preparation and regulatory response.

    • CTD

    • Non-clinical Data

    • Documentation

    • Regulatory Response

  • GLP Certification Consulting

    We support certification response strategies aligned with KGLP and global GLP standards.

    • KGLP

    • Global GLP

    • Certification Response

    • Strategy Establishment

Efficacy Evaluation

Through small-animal and large-animal-based efficacy evaluation of pharmaceuticals and medical devices, we provide non-clinical data customized by indication.

Small Animals
Pharmaceuticals
  • Digestive Diseases

  • Metabolic Diseases

  • Cardiovascular Diseases

  • Anticancer Efficacy

  • Ophthalmic Diseases

Medical Devices
  • Class 1–4 Medical Devices

Large Animals
Pharmaceuticals
  • Digestive Diseases

  • Musculoskeletal Diseases

  • Dental Diseases

  • Cardiovascular Diseases

Medical Devices
  • Class 1–4 Medical Devices

Performance

Based on our experience conducting domestic and international non-clinical projects, we provide optimal testing strategies.

  • Domestic GLP Projects

    410+

  • Venture Non-clinical Consulting

    25+

  • Global CRO Collaborations

    4+

Domestic Business Performance

  • Domestic GLP Institutions

    Experience conducting more than 410 projects in new drugs, health functional foods, and cosmetics.

  • Domestic NGLP Institutions

    Conducted numerous non-clinical projects centered on efficacy testing and toxicity screening.

  • Domestic Venture New Drug Projects

    Conducted 25 non-clinical consulting projects for venture new drug development.

International Business

  • CRL (Charles River)

    Conducted Mini-Pig chronic toxicity and PK projects

  • SEKISUI

    Conducted ADME non-clinical evaluation projects

  • PharmaLegacy

    Conducted monkey toxicity and PK projects

  • Vivotecnia

    Conducted rat / monkey chronic toxicity and reproductive toxicity studies

Equipment & Research Infrastructure

LCS possesses core research equipment infrastructure required for efficacy evaluation, including endoscopy, CT, ultrasound, X-Ray, and angiography equipment, to precisely conduct non-clinical efficacy evaluation of pharmaceuticals and medical devices.

  • Endoscopy System
  • Endoscopy SCOP
  • CT
  • Endoscopy SCOP Cleaning Equipment
  • X-Ray Equipment
  • Ultrasound
  • Angiography Equipment
  • Respiratory Anesthesia Maintenance System
  • Imaging Diagnostic Equipment
    • CT Scanner

    • Ultrasonography

    • X-Ray

    • C-Arm

    • Angiography Equipment

  • Endoscopy / Cleaning Systems
    • Endoscopic System

    • Endoscopic Scope

    • Washer

  • Surgery / Anesthesia / Monitoring
    • Ventilator

    • Anesthesia M/C

    • Patient Monitor

    • Electro Surgical Unit

    • Drill Set

  • Experimental Maintenance Equipment
    • Metabolic Cage

    • Temperature Control

    • Plaster Cutter

Network

Based on the Meditip Family and a collaborative network of domestic and international CROs, we provide an optimal non-clinical execution system.

Domestic & International Partner CROs

Domestic CRO
GLP
  • Corestem Chemon

  • Biotoxtech

  • DT&CRO

  • Central Bio

  • HLB Biocode

  • KPR

  • HNHBIO

  • KCL

NGLP
  • HLB Biostep

  • KFB

  • QBest Bio

  • L2 Science

  • SPMED

  • CHAON

  • HUMIC

International CRO
GLP
  • Frontage (USA / China)

  • Experimur (USA)

  • Vivotecnia (Spain)

  • Altasciences (USA)

  • JOINN (China)

NGLP
  • PharmaLegacy (China)

  • Sekisui (Japan)

LCS Contact

From non-clinical strategy to testing site connections,
LCS experts consult with you directly.

To match you with the optimal non-clinical strategy and CRO network for your test
objectives, indications, schedule, and budget, LCS's key leaders provide fast, direct consultation.